Feed SCL
SC

Stepan Company

SCL · NYSE

$61.95 -1.46% (-$0.92)
1M -2.75%
Market Cap $1.43B
P/E Ratio -
Div. Yield 2.51%
ROE 0.22%

Bulios Fair Price

$55.19

10.9% downside

Current Price

$61.95

Undervalued Fair Value Overvalued

According to Bulios Fair Price, SCL is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
5/9
Valuation
65 /100
Fair
P/B 1.18x
EV/EBITDA 12.68x
P/S 0.59x
Growth
13 /100
Declining
Book val. growth 2.18%
EPS growth 31.51%
Rev. growth 5.61%
Profitability
19 /100
Weak
Op. margin 3.34%
Gross margin 11.81%
FCF margin 1.39%
Quality
57 /100
Average
ROA 0.11%
ROIC 22.58%
Asset turnover 1.02x
Debt
52 /100
Moderate
Int. coverage 1.49x
Debt/Equity 0.58x
Net debt/EBITDA 3.72x
Stability
93 /100
Stable
EPS volatility 50.07%
Beta 0.94x
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about SCL
Online

About the company

Stepan Company is an American chemical company focused on the production of specialty chemicals and products for various industrial applications, including personal care, automotive, textiles, and other sectors. The company emphasizes innovation, sustainability, and reducing the environmental impact of its products and processes.

Sector

Basic Materials

Industry

Chemicals - Specialty

CEO

Luis E. Rojo

Employees

2,328

Headquarters

Northbrook

Upcoming events

04 NOV

Earnings

Upcoming earnings report

45d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.